Stockscreener 앱 받기
466.30
0.91%
-4.225
Vertex Pharmaceuticals Inc 주식(VRTX)의 최신 뉴스
Does WuXi Trispecific T-cell Engager Deal Reshape the Bull Case for Vertex Pharmaceuticals (VRTX)? - simplywall.st
Is Vertex Pharmaceuticals (VRTX) Pricing Reflect Long Term Cash Flow Potential After Recent Pullback - Yahoo Finance
Vertex Pharma wins EU backing to expand label for Kaftrio cystic fibrosis drug - MSN
The Truth About Vertex Pharma: Why Wall Street Suddenly Can’t Shut Up - AD HOC NEWS
Callan Family Office LLC Has $4.39 Million Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Machina Capital S.A.S. Acquires Shares of 11,167 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Rep. David Taylor Sells Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock - MarketBeat
WUXI BIO, Vertex Pharmaceuticals Sign License & Research Service Agreement for T-cell Engager - AASTOCKS.com
Biopharma bites: Updated data for Ultragenyx's gene therapy, AI newco's $13.5M seed round, plus more from NMD, Vertex - FirstWord Pharma
Is Trending Stock Vertex Pharmaceuticals Incorporated (VRTX) a Buy Now? - Yahoo Finance
Here's How Much a $1000 Investment in Vertex Pharmaceuticals Made 10 Years Ago Would Be Worth Today - Yahoo Finance
WuXi licenses trispecific immune engager to Vertex - The Pharma Letter
Vertex (VRTX) Secures Exclusive Rights for Innovative Autoimmune Treatment - GuruFocus
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by WCM Investment Management LLC - MarketBeat
Mediolanum International Funds Ltd Purchases 3,050 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
WuXi Biologics Jumps On Pact With Vertex Pharma For T-Cell Engager In Autoimmune Disease - Nasdaq
Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica - GlobeNewswire Inc.
WuXi Biologics and Vertex Pharmaceuticals Partner to Develop T-Cell Engager Immunotherapies - geneonline.com
WuXi Biologics Inc. and Vertex Pharmaceuticals Incorporated Sign License and Research Service Agreement for T-Cell Engager - marketscreener.com
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager - marketscreener.com
Vertex Pharmaceuticals (VRTX) Stock Analysis: A Healthcare Giant with 9.45% Potential Upside - DirectorsTalk Interviews
Top Biotech Stocks To Watch TodayFebruary 2nd - MarketBeat
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Presents a Compelling Growth and Breakout Opportunity - Chartmill
Principal Financial Group Inc. Reduces Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Atle Fund Management AB Reduces Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Holdings Lifted by National Pension Service - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by TD Waterhouse Canada Inc. - MarketBeat
Vertex Pain Setback Prompts Fund Exit And Recheck Of Valuation Gap - Yahoo Finance
Why Analysts Are Positive on Vertex Pharmaceuticals Incorporated (VRTX)'s Story - Finviz
Biotech Stocks To Keep An Eye OnJanuary 31st - MarketBeat
Why Analysts Are Positive on Vertex Pharmaceuticals Incorporated (VRTX)’s Story - Insider Monkey
Welch & Forbes LLC Buys 3,102 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
AustralianSuper Pty Ltd Trims Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today - Yahoo Finance
10 Most Profitable Healthcare Stocks to Buy - Insider Monkey
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Fidelis Capital Partners LLC - MarketBeat
Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals - The Globe and Mail
Best Biotech Stocks To Watch NowJanuary 29th - MarketBeat
What's Driving the Market Sentiment Around Vertex Pharmaceuticals Inc? - Benzinga
Assessing Vertex Pharmaceuticals (VRTX) Valuation After Fund Exit And Setback For Journavx Pain Label - simplywall.st
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by Strategic Advisors LLC - MarketBeat
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Presents a Compelling Value Case - Chartmill
New York State Common Retirement Fund Cuts Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Mirae Asset Global Investments Co. Ltd. Buys 6,468 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Truist Financial Corp Sells 66,225 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharma upgraded at RBC Capital Markets citing upside in 2026 - MSN
Barclays Upgrades Vertex Pharmaceuticals (VRTX) - Nasdaq
Promising Biotech Stocks To ResearchJanuary 28th - MarketBeat
Barclays Upgrades Vertex Pharmaceuticals (VRTX) with Increased P - GuruFocus
Bank of America Securities Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX) - The Globe and Mail
Little House Capital LLC Increases Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Stonegate Investment Group LLC Has $769,000 Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Here’s Why Hardman Johnston Global Equity Strategy Sold Vertex Pharmaceuticals (VRTX) - Yahoo Finance
Vertex Pharmaceuticals (VRTX) Receives a Buy from Citi - The Globe and Mail
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by EFG Asset Management North America Corp. - MarketBeat
Promising Biotech Stocks To Follow NowJanuary 27th - MarketBeat
Barlow Wealth Partners Inc. Sells 21,078 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Physician Views Results: Vertex's Journavx impresses in acute pain, as case for chronic comes into focus - FirstWord Pharma
VRTX Stock Surges 6.1% With A 5-day Winning Spree On Analyst Upgrades - Trefis
TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals - Time Magazine
Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Leader With 8% Potential Upside - DirectorsTalk Interviews
Vertex Pharmaceuticals (VRTX) Sees Price Target Increase by UBS to $545 | VRTX Stock News - GuruFocus
Best Biotech Stocks To Follow NowJanuary 26th - MarketBeat
Vertex Pharmaceuticals price target raised to $545 from $535 at UBS - TipRanks
Lbp Am Sa Grows Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
UniSuper Management Pty Ltd Has $8.03 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Baillie Gifford & Co. Sells 5,423 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
AMF Tjanstepension AB Reduces Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
A Look At Vertex Pharmaceuticals (VRTX) Valuation After Recent Analyst Upgrades And CASGEVY Approval - Yahoo Finance
1.07%
0.89%
자본화:
|
볼륨(24시간):